NovoCure Ltd (NASDAQ:NVCR) filed a Form 8-K with the Securities and Exchange Commission on February 11, 2026, disclosing a material event.
NovoCure Ltd's stock currently trades at $10.50 with a market capitalization of $1.5B. The Healthcare company's stock moved following the disclosure.